Saroja Pharma Industries India Limited
ListedSMEChemicals & Pharmaceuticals · NSE
Saroja Pharma Industries India Limited, incorporated in 2019, is engaged in trading, exporting, and supplying specialty chemicals and APIs. The company deals in three major product categories: chemicals, pharma intermediaries, and veterinary pharma APIs. It supplies products like Liquid Bromine (used as an agro-intermediate), Ethyl Acetate (used as an API solvent), and other pharma-based chemicals used in human and veterinary medicines. APIs or bulk actives are the key ingredients used in producing finished dosage forms like tablets, capsules, and liquids. The company exports its products to international markets including Pakistan, Egypt, Russia, Jordan, Hong Kong, Singapore, and more.
Price Band
₹84
Issue Size
₹9.11 Cr
Lot Size
1600 shares
GMP
—
Est. Listing
₹84
at current GMP
Subscribed
8.86x
overall
Open
31 Aug 2023
Close
5 Sep 2023
Allotment
12 Sep 2023
Refund
13 Sep 2023
Demat Credit
14 Sep 2023
Listing
13 Sep 2023
Last updated 12 days ago
Live Grey Market Premium
Saroja Pharma Industries India Limited GMP Today
Last updated: 19 Oct 2026
Current Premium
₹00.0%
Issue Price (Upper)
₹84
Band: ₹84
Estimated Listing Price
₹84
Upper price + GMP
Lot Size
1600 shares
Min investment ₹1,34,400
Estimated Profit / Lot
₹0
1600 × ₹0
Saroja Pharma Industries India Limited GMP Historical Trend
GMP History
Grey Market Premium trend
—
▲ 0 today
Updated 1 minute ago
Estimated Listing Price
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | — | 0.0% | ₹84 |
| 30 Oct 2026 | — | 0.0% | ₹84 |
| 29 Oct 2026 | — | 0.0% | ₹84 |
GMP is unofficial market data. Not a guarantee of listing performance.
About Saroja Pharma Industries India Limited Public Issue & Market Profile
Saroja Pharma Industries India Limited is bringing an initial public offering (IPO) in the Chemicals & Pharmaceuticals sector with an aggregate issue size of ₹9.11 Crores. The shares are offered at a price band of ₹84 to ₹84 per equity share on NSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.
Public Issue & Pricing Context:
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Basis of Allotment & Listing Timeline:
Following the close of bidding on 2023-09-05, the basis of allotment is scheduled to be finalized on 2023-09-12. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Kfin Technologies Limited) or the BSE allotment checking window.
Frequently Asked Questions
What is Saroja Pharma Industries India Limited IPO GMP today?
The latest grey market premium for Saroja Pharma Industries India Limited IPO is ₹0, which indicates an expected listing price of ₹84.
What does Kostak Rate and Sauda mean in IPO GMP?
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
Is Grey Market Premium officially recognized?
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.